<DOC>
	<DOCNO>NCT02943954</DOCNO>
	<brief_summary>Although current guideline recommend fractional flow reserve ( FFR ) identify haemodynamically relevant coronary lesion ( ) stable patient evidence ischaemia available ( Class I , Level Evidence : A ) , publish study assess usefulness FFR guide percutaneous coronary intervention ( PCI ) ST-elevation myocardial infarction ( STEMI ) patient multi-vessel disease ( MVD ) . The main objective study determine whether , STEMI patient MVD amenable PCI , use FFR addition angiography improve cardiovascular outcome , compare current practice angiography- guide PCI , improve appropriateness revascularisations assess relevance non-culprit lesion context STEMI multivessel coronary artery disease . The secondary objective ass safety cost-effectiveness FFR-guided strategy compare angiography-guided strategy .</brief_summary>
	<brief_title>FLOW Evaluation Guide Revascularization Multi-vessel ST-elevation Myocardial Infarction</brief_title>
	<detailed_description>The optimal revascularisation strategy STEMI patient MVD currently debate . Recent data suggest MV-PCI may appropriate option treat patient . Consequently , real challenge become define MVD , context acute MI , order limit revascularisation PCI vessel truly need . Visual estimation degree coronary stenosis poor indicator haemodynamic severity . FFR precisely design recommended current guideline provide objective guidance functional assessment lesion severity coronary angiography stable patient , validate STEMI patient MVD . The purpose present trial therefore investigate relevance FFR guide revascularisation management patient acute stage STEMI . STEMI patient successful culprit lesion PCI ( primary , rescue pharmaco-invasive ) ≥ 50 % diameter stenosis visual estimate , revascularization contemplate judged amenable PCI least one additional non-culprit lesion randomize two group : angiography-guided PCI FFR-guided PCI . If patient randomize angiography-guided PCI , lesion indicate beforehand treat . If patient randomize FFR-guided PCI , measurement FFR non-infarct related lesion ( ) perform lesion FFR ≤ 0.80 treat . The use drug-eluting stent encourage strategy . All patient receive optimal medical therapy ( include dual antiplatelet therapy , beta-blockers , statin , ACE-I ARB ) recommend international guideline strategy . Clinical follow-up perform discharge , 30-day , 6 month one-year . Rates major adverse cardiac event , functional class number anti-anginal medication use collect . If patient rehospitalized since index hospital discharge , discharge summary relevant information collect .</detailed_description>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<criteria>STEMI patient ≥ 18 year old successful culprit lesion PCI ( primary , rescue pharmacoinvasive ) ≥ 50 % stenosis judge amenable PCI least one additional nonculprit lesion Written inform consent Patients cardiogenic shock ( SBP &lt; 90 mmHg clinical sign low output patient require inotropic agent ) Patients MVD refer surgery CABG treatment acute complication ( e.g . ventricular septal rupture ) Patients onevessel disease Previous coronary bypass surgery Extremely tortuous , calcify coronary vessel chronic total occlusion ( CTO ) Life expectancy &lt; 2 year Patients know hypersensitivity adenosine Pregnancy Participation another interventional therapeutic study time within 3 month prior begin present study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Fractional Flow Reserve</keyword>
</DOC>